FdaApplication

BLA 761406

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBiocon Biologics Inc.
application_typeBLA
approval_date2024-11-29

Products (6)

ProductActive ingredientStrengthDosage form
YESINTEKUSTEKINUMAB-KFCE45MG/0.5MLInjection
YESINTEKUSTEKINUMAB-KFCE45MG/0.5MLInjection
YESINTEK—130MG/26ML (5MG/ML)Injection
YESINTEK—90MG/MLInjection
YESINTEK—45MG/0.5MLInjection
YESINTEK—90MG/MLInjection

6 products